Novel medical therapies for gastroesophageal reflux disease beyond proton-pump inhibitors

Gastroenterology Clinics of North America

Volumn 31, Issue 4 SUPPL., 2002, Pages

  Richter, Joel E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; ATROPINE; BACLOFEN; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DEVAZEPIDE; LOPERAMIDE; LOXIGLUMIDE; MORPHINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROTON PUMP INHIBITOR;

CONSTIPATION; DROWSINESS; GASTROESOPHAGEAL REFLUX; HUMAN; MORPHINE ADDICTION; NAUSEA; REVIEW; SEIZURE; SIDE EFFECT; SMOOTH MUSCLE RELAXATION; SYMPTOMATOLOGY;

EID: 0036896109     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(02)00045-6     Document Type: Review

References (14)

1. Mittal RK, Holloway RH, Penagini R, et al. Transient lower esophageal sphincter relaxation. Gastroenterology 1995;109:601-10.
2. Dent J, Holloway RH, Toouli J, et al. Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastro-oesophageal reflux. Gut 1988;29:1020-8.
3. Holloway RH, Hongo M, Berger K, et al. Gastric distention: A mechanism for postprandial gastroesophageal reflux. Gastroenterology 1985;89:779-84.
4. Boulant J, Fioramonti J, Dapoigny M, et al. Cholecystokinin and nitric oxide in transient lower esophageal sphincter relaxation to gastric distention in dogs. Gastroenterology 1994;107: 1059-66.
5. A receptors in transient lower esophageal sphincter relaxations triggered by gastric distension. Am J Gastroenterol 1998;93:1823-8.
6. Mittal RK, Holloway R, Dent J. Effect of atropine on the frequency of reflux and transient lower esophageal sphincter relaxation in normal subjects. Gastroenterology 1995;109: 1547-54.
7. Lidums I, Checklin H, Mittal RK, et al. Effect of atropine on gastro-oesophageal reflux and transient lower oesophageal sphincter relaxations in patients with gastro-oesophageal reflux disease. Gut 1998;43:12-6.
8. Hirsch DP, Holloway RH, Tytgat GN, et al. Involvement of nitric oxide in human transient lower esophageal sphincter relaxations and esophageal primary peristalsis. Gastroenterology 1998;115:374-80.
9. B agonist baclofen in normal subjects. Gastroenterology 2000;118:7-13.
10. Penagini R, Bianchi PA. Effect of morphine on gastroesophageal reflux and transient lower esophageal sphincter relaxation. Gastroenterology 1997;113:409-14.
11. Allocca M, Mangano M, Colombo P, et al. Does loperamide decrease gastro-oesophageal reflux in patients with reflux disease? [abstract]. Gastroenterology 1999;116:A111.
12. Zhang Q, Lehmann A, Rigda R, et al. Control of transient lower oesophageal sphincter relaxation and reflux by the GABAB agonist baclofen in patients with gastro-oesophageal reflux disease. Gut 2002;50:19-24.
13. Vela MF, Tutuian R, Katz PO, et al. Baclofen reduces both acid and nonacid gastroesophageal reflux: A study using combined multichannel intraluminal impedance and pH [abstract]. Am J Gastroenterol 2001;96:542.
14. Hirsch DP, Tiel-Van Buul MM, Tytgat GNJ, et al. Effect of L-NMMA on post-prandial transient lower esophageal sphincter relaxations in healthy volunteers [abstract]. Neurogastroenterol Motil 1999;11:264.